Jackson Creek Investment Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.13M Sell
14,298
-5,515
-28% -$442K 0.38% 114
2026
Q1
$1.52M Sell
19,813
-778
-4% -$60.7K 0.45% 106
2025
Q4
$1.63M Sell
20,591
-740
-3% -$64.1K 0.48% 93
2025
Q3
$1.95M Sell
21,331
-8
-0% -$652 0.57% 55
2025
Q2
$1.39M Buy
21,339
+2,747
+15% +$179K 0.38% 147
2025
Q1
$1.25M Sell
18,592
-11
-0.1% -$657 0.4% 137
2024
Q4
$1.03M Sell
18,603
-580
-3% -$33.3K 0.31% 168
2024
Q3
$1.14M Buy
19,183
+4,270
+29% +$260K 0.34% 162
2024
Q2
$950K Sell
14,913
-34
-0.2% -$2.21K 0.35% 164
2024
Q1
$1.03M Sell
14,947
-29
-0.2% -$1.75K 0.37% 144
2023
Q4
$826K Sell
14,976
-7
-0% -$385 0.32% 173
2023
Q3
$870K Sell
14,983
-5,387
-26% -$311K 0.37% 134
2023
Q2
$1.1M Buy
+20,370
New +$903K 0.44% 55
2022
Q4
Sell
-32,024
Closed -$1.03M 302
2022
Q3
$1.03M Sell
32,024
-674
-2% -$23.1K 0.48% 31
2022
Q2
$1.12M Buy
+32,698
New +$943K 0.45% 39

Other funds holding ANIP

Jackson Creek Investment Advisors's ANIP Position: Q2 2026 in Review

Jackson Creek Investment Advisors reduced its ANI Pharmaceuticals (ANIP) stake by 28% in Q2 2026, selling an estimated $442K and leaving 14,298 shares worth $1.13M. The position accounts for 0.38% of the portfolio, ranked #114.

Jackson Creek Investment Advisors first reported a position in ANIP in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.95M in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • Jackson Creek Investment Advisors held 14,298 shares of ANI Pharmaceuticals worth $1.13M as of Q2 2026.
  • Jackson Creek Investment Advisors sold 5,515 ANI Pharmaceuticals shares in Q2 2026, an estimated $442K.
  • ANI Pharmaceuticals made up 0.38% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #114 holding.
  • Jackson Creek Investment Advisors first reported a position in ANI Pharmaceuticals in Q2 2022 and has held it in 15 quarters since.
  • Jackson Creek Investment Advisors's ANI Pharmaceuticals position peaked at $1.95M in Q3 2025.
  • 308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.